CI

At a glance

ClinicalIndex Comparison Record
N/AWithdrawn· 0 enrolled
Drug / intervention
Electro-Stimulation of Yongquan (K1) Acupoint +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00430313
NCT00430313N/AWithdrawn
Withdrawn

Effects of Acupoint Electro-stimulation on Preventing Nausea and Vomiting Induced by Cisplatin or Oxaliplatin

M.D. Anderson Cancer Center·interventional·Posted Feb 1, 2007·Updated Mar 29, 2023

In Brief

A clinical study evaluating Electro-Stimulation of Yongquan (K1) Acupoint for Liver Cancer and Liver Metastasis. Withdrawn before enrollment.

Signals

Trial was withdrawn before enrollment

Detailed Summary

Objectives: This protocol is part of a larger grant funded by the NCI to create an international research center to study Traditional Chinese Medicine (TCM). All of the patients enrolled in this study will be treated at the Cancer Hospital, Fudan University, investigator's sister institution in Shanghai, China. No patients will be seen at MDACC. This protocol will be overseen by the Fudan University Institutional Review Board (IRB00002408) which has Federal Wide Assurance through the U.S. Department of Health \& Human Services (Approved: April 25, 2002). The research nurses have received training at MDACC and will receive regular oversight by MDACC personnel. The purpose of this randomized, placebo controlled study is to determine the effects of K1 acustimulation at controlling chemotherapy induced nausea and vomiting (CINV). 1. The primary aim of this study is to determine the effects of electro-stimulation of Yongquan (K1) acupoint on preventing nausea and vomiting induced by cisplatin or oxaliplatin. 2. The secondary aim is to observe the effects of electro-stimulation (ES) of Yongquan (K1) acupoint on pain, insomnia, abdominal distention, dizziness, and general sense of well-being.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--

Timeline

N/AWithdrawnFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 1, 2007
Enrollment StartJan 4, 2007
Primary CompletionAug 10, 2022
TodayJul 1, 2026
Enrollment to primary: 15.6 yearsPosted 19.4 years ago

Interventions

Electro-Stimulation of Yongquan (K1) Acupointprocedure

Electro-stimulation at an active (responsive) acupuncture site on the bottom of the foot.

Electro-Stimulation of Yongquan (K1) Acupointprocedure

Electro-stimulation at a inactive site on the bottom of the foot (a "placebo" site).